Monthly information on share capital and company voting rights
Cellectis (NASDAQ:CLLS) has released its monthly share capital and voting rights report as of June 30, 2025. The company reported a total of 100,325,229 shares in its capital structure and 89,428,630 voting rights.
This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, as the company is listed on Euronext Growth.
Cellectis (NASDAQ:CLLS) ha pubblicato il suo rapporto mensile sul capitale sociale e sui diritti di voto al 30 giugno 2025. La societ脿 ha comunicato un totale di 100.325.229 azioni nella sua struttura patrimoniale e 89.428.630 diritti di voto.
Questa comunicazione viene effettuata in conformit脿 all'articolo 223-16 del Regolamento Generale dell'autorit脿 francese dei mercati finanziari, poich茅 la societ脿 猫 quotata su Euronext Growth.
Cellectis (NASDAQ:CLLS) ha publicado su informe mensual sobre el capital social y los derechos de voto al 30 de junio de 2025. La compa帽铆a report贸 un total de 100.325.229 acciones en su estructura de capital y 89.428.630 derechos de voto.
Esta divulgaci贸n se realiza de conformidad con el art铆culo 223-16 del Reglamento General de la autoridad francesa de mercados financieros, dado que la empresa cotiza en Euronext Growth.
Cellectis (NASDAQ:CLLS)電� 2025雲� 6鞗� 30鞚� 旮办 鞗旉皠 鞛愲掣旮� 氚� 鞚橁舶甓� 氤搓碃靹滊ゼ 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 鞛愲掣 甑“鞐� 齑� 100,325,229欤�鞕赌 89,428,630 鞚橁舶甓�鞚� 鞛堧嫟瓿� 氤搓碃頄堨姷雼堧嫟.
鞚� 瓿奠嫓電� 須岇偓臧� Euronext Growth鞐� 靸侅灔霅橃柎 鞛堨溂氙�搿� 頂勲瀾鞀� 旮堨湹鞁滌灔觳� 鞚茧皹攴滌爼 鞝�223-16臁办棎 霐半澕 鞚措（鞏挫鞀惦媹雼�.
Cellectis (NASDAQ:CLLS) a publi茅 son rapport mensuel sur le capital social et les droits de vote au 30 juin 2025. La soci茅t茅 a d茅clar茅 un total de 100 325 229 actions dans sa structure de capital et 89 428 630 droits de vote.
Cette divulgation est effectu茅e conform茅ment 脿 l'article 223-16 du R猫glement G茅n茅ral de l'Autorit茅 des march茅s financiers fran莽aise, la soci茅t茅 茅tant cot茅e sur Euronext Growth.
Cellectis (NASDAQ:CLLS) hat seinen monatlichen Bericht 眉ber das Grundkapital und die Stimmrechte zum 30. Juni 2025 ver枚ffentlicht. Das Unternehmen meldete insgesamt 100.325.229 Aktien in seiner Kapitalstruktur und 89.428.630 Stimmrechte.
Diese Offenlegung erfolgt gem盲脽 Artikel 223-16 der Allgemeinen Verordnung der franz枚sischen Finanzmarktaufsicht, da das Unternehmen an Euronext Growth notiert ist.
- None.
- None.
PARIS, July 04, 2025 (GLOBE NEWSWIRE) --
(Article 223-16 of General Regulation of the French financial markets authority)
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 06/30/2025 | 100,325,229 | 89,428,630 |
For further information on Cellectis, please contact:鈥赌赌赌�
Media contacts:听听听听听听听
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,
Patricia Sosa Navarro, Chief of Staff to the CEO,聽+33 (0)7 76 77 46 93
Investor Relations contact:听听听听听听听
Arthur Stril, Chief Financial Officer & Chief Business Officer,
Attachment
FAQ
What is the current number of shares outstanding for Cellectis (CLLS) as of June 2025?
How many voting rights does Cellectis (CLLS) have as of June 2025?
Where is Cellectis (CLLS) stock listed?
Who should investors contact for Cellectis (CLLS) investor relations?
